Trial Profile
Clinical Trials Insight: 700024093
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 25 Jun 2007
Price :
$35
*
At a glance
- Drugs INGN 241 (Primary)
- Indications Solid tumours
- Focus Registrational; Therapeutic Use
- Sponsors Introgen Therapeutics
- 25 Jun 2007 Status change
- 25 Jun 2007 New trial record.